Evidence map›Paper›PMID 36560807›Full record

ArticleViruses2022

A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines.

Charlotte Nyblade, Casey Hensley, Viviana Parreño, Peng Zhou, Maggie Frazier, Annie Frazier, Ashwin Ramesh, Shaohua Lei, Juan Ignacio Degiuseppe, Ming Tan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Charlotte NybladeDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Casey HensleyDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Viviana ParreñoDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Peng ZhouDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Maggie FrazierDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Annie FrazierDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Ashwin RameshDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.ORCID 0000-0002-4009-6823
Shaohua LeiDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.
Juan Ignacio DegiuseppeLaboratory of Viral Gastroenteritis, National Institute for Infectious Diseases (INEI-ANLIS "Dr. Carlos G. Malbrán"), Ciudad Autónoma de Buenos Aires 1281, Argentina.ORCID 0000-0002-2181-7795
Ming TanDivision of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.ORCID 0000-0002-6489-5507
Lijuan YuanDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA.ORCID 0000-0003-0709-5228
Virginia–Maryland College of Veterinary Medicine · USAdministración Nacional de Laboratorios e Institutos de Salud · ARCincinnati Children's Hospital Medical Center · USConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

A Nanoparticle-Based Multivalent Rotavirus VaccineR56AI148426 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI TAN, MING · 2020 to 2020
$626k
NIAID NIH HHS R56 AI148426
6 · The paper itself

Abstract

Human rotavirus (HRV) is a leading cause of gastroenteritis in children under 5 years of age. Licensed vaccines containing G1P[8] and G1-4P[8] strains are less efficacious against newly emerging P[6] strains, indicating an urgent need for better cross protective vaccines. Here, we report our development of a new gnotobiotic (Gn) pig model of P[6] HRV infection and disease as a tool for evaluating potential vaccine candidates. The Arg HRV (G4P[6]) strain was derived from a diarrheic human infant stool sample and determined to be free of other viruses by metagenomic sequencing. Neonatal Gn pigs were orally inoculated with the stool suspension containing 5.6 × 10

Indexed as

RotavirusRotavirus InfectionsRotavirus VaccinesAnimalsChildChild, PreschoolFecesGerm-Free LifeHumansInfantInfant, NewbornSwineRotavirus Vaccinesdiarrheagnotobiotic pig modelhuman rotavirusP[6] genotypevaccine evaluation

Identifiers

PMID36560807
PMCPMC9784283
OpenAlexW4312194600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.